The range of multiple sclerosis associated with neurofibromatosis type 1

Journal of Neurology Neurosurgery and Psychiatry

Volumn 71, Issue 5, 2001, Pages 679-681

  Perini, P ^a   Gallo, P ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Multiple sclerosis; Neurofibromatosis

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; FEMALE; HUMAN; ITALY; MALE; MULTIPLE SCLEROSIS; NEUROFIBROMATOSIS; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; STEROID THERAPY;

ADULT; BRAIN; BRAIN STEM; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOGLOBULIN G; ITALY; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROFIBROMATOSIS 1; PREVALENCE; SPINAL CORD;

EID: 0034777235     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.71.5.679     Document Type: Article

References (15)

1. Shen MH, Harper PS, Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF-1). J Med Genet 1996;33:1-17.
2. Huson SM, Harper PS, Compston DAS. Von Reckiinghausen neurofibromatosis: a clinical and population study in south east Wales. Brain 1988;111:1355-81.
3. Huson SM, Compston DAS, Clark P, et al. A genetic study of von Recklinghausen disease in south Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 1989;26:704-11.
4. Samuelsson B, Samuelsson S. Neurofibromatosis in Gothenburg, Sweden. I. Background, study design, and epidemiology. Neurofibromatosis 1989;2:6-22.
5. Friedman JM. Epidemiology of neurofibromatosis type I. Am J Med Genet 1999;89:1-6.
6. Ferner RE, Hughes RAC, Weinman J. Intellectual impairment in neurofibromatosis 1. J Neurol Sci 1996;138:125-33.
7. Creange A, Zeller J, Rostaing-Rigattieri S, et al. Neurological complications of neurofibromatosis in adulthood. Brain 1999;122:473-81.
8. Ferner RE, Hughes RAC, Johnson MR. Neurofibromatosis 1 and multiple sclerosis. J Neurol Neurosurg Psychiatry 1995;58:582-5.
9. Masson C, Colombani J-M. Neurofibromatose 1 et sclérose en plaques. Rev Neurol 1997;153:684-6.
10. Johnson MR, Ferner RE, Bobrow M, et al. Detailed analysis of the oligodendrocyte myelin glycoprotein gene in four patients with neurofibromatosis 1 and primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 2000;68: 643-6.
11. Li Y, O'Connel P, Breindenbach HH, et al. Genomic organization of the neurofibromatosis 1 gene (NF1). Genomics 1995;25:9-18.
12. Hinks LJ, Price SE, Mason CR, et al. Single strand conformation analysis of two genes contained in the first intron of the neurofibromatosis type 1 gene in patients with multiple sclerosis. Neuropathol Appl Neurobiol 1995;21:201-7.
13. Clementi M, Barbujani G, Turolla L, et al. Neurofibromatosis-1: a maximum likelihood estimation of mutation rate. Hum Genet 1990;84:116-18.
14. Jenne DE, Tinschert S, Stegmenn E, et al. A common set of at least 11 functional genes is lost in the majority of NF1 patients with gross deletions. Genomics 2000;66:93-7.
15. Viskochil D. Neurofibromatosis 1. Am J Med Genet 1999;89:v-vii.